Cargando…
Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745997/ https://www.ncbi.nlm.nih.gov/pubmed/31723786 http://dx.doi.org/10.1097/HS9.0000000000000137 |
| _version_ | 1783451635682377728 |
|---|---|
| author | Hallam, Simon |
| author_facet | Hallam, Simon |
| author_sort | Hallam, Simon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6745997 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67459972019-11-13 Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma Hallam, Simon Hemasphere HemaTopics Wolters Kluwer Health 2018-07-26 /pmc/articles/PMC6745997/ /pubmed/31723786 http://dx.doi.org/10.1097/HS9.0000000000000137 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
| spellingShingle | HemaTopics Hallam, Simon Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma |
| title | Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma |
| title_full | Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma |
| title_fullStr | Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma |
| title_full_unstemmed | Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma |
| title_short | Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma |
| title_sort | dual immunotherapy adds value in relapsed/refractory hodgkin lymphoma |
| topic | HemaTopics |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745997/ https://www.ncbi.nlm.nih.gov/pubmed/31723786 http://dx.doi.org/10.1097/HS9.0000000000000137 |
| work_keys_str_mv | AT hallamsimon dualimmunotherapyaddsvalueinrelapsedrefractoryhodgkinlymphoma |